← Every applicant
Bristol FDA Approvals
5 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| ELIQUISNew drugApr 17, 2025SUSPENSION, ORAL |
| AUGTYRONew drugNov 15, 2023CAPSULE, ORAL |
| KRAZATINew drugDec 12, 2022TABLET, ORAL |
| SOTYKTUNew drugSep 9, 2022TABLET, ORAL |
| CAMZYOSNew drugApr 28, 2022CAPSULE, ORAL |